Atchley v. AstraZeneca UK Limited, No. 20-7077 (D.C. Cir. 2022)
Annotate this Case
Plaintiffs, victims of Jaysh al-Mahdi terrorist attacks and the victims' family members, filed suit alleging that defendants, large medical supply and manufacturing companies, knowingly gave substantial support to the attacks against them in violation of the Anti-Terrorism Act (ATA), as amended by the Justice Against Sponsors of Terrorism Act (JASTA), and state law. Plaintiffs claim that defendants, aware of Jaysh al-Mahdi's command of the Ministry, secured lucrative medical-supply contracts with the Ministry by giving corrupt payments and valuable gifts to Jaysh al-Mahdi. The district court held that the complaint failed to state claims for either direct or secondary (aiding-and-abetting) liability under the ATA, and that it lacked personal jurisdiction over six foreign defendants.
The DC Circuit reversed on three issues and remanded the balance of the issues to be addressed by the district court consistent with the court's opinion. First, the court concluded that plaintiffs plead facts that suffice to support their aiding-and-abetting claim at the motion-to-dismiss stage. Second, with respect to the direct liability claim, the court concluded that plaintiffs have adequately pleaded that defendants' payments to Jaysh al Mahdi proximately caused plaintiffs' injuries. Third, the court concluded that the district court's personal jurisdiction analysis was unduly restrictive.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.